Logo image of PTI

Proteostasis Ther (PTI) Stock Price, Forecast & Analysis

USA - NYSE:PTI -

1.11
-0.04 (-3.48%)
Last: 12/22/2020, 8:00:01 PM
1.1
-0.01 (-0.9%)
After Hours: 12/22/2020, 8:00:01 PM

PTI Key Statistics, Chart & Performance

Key Statistics
Market Cap57.93M
Revenue(TTM)N/A
Net Income(TTM)-38796000
Shares52.19M
Float36.18M
52 Week High2.39
52 Week Low0.87
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.75
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


PTI short term performance overview.The bars show the price performance of PTI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

PTI long term performance overview.The bars show the price performance of PTI in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of PTI is 1.11 null. In the past month the price increased by 8.82%. In the past year, price decreased by -50.22%.

Proteostasis Ther / PTI Daily stock chart

PTI Latest News, Press Relases and Analysis

5 years ago - By: Proteostasis Therapeutics, Inc.
News Image
5 years ago - By: Capital Market Laboratories
News Image
5 years ago - By: Proteostasis Therapeutics, Inc.
News Image
5 years ago - By: Benzinga - Mentions: LCI ACOR BLUE DBVT ...
News Image
5 years ago - By: Zacks Investment Research
News Image
5 years ago - By: Zacks Investment Research - Mentions: CI DRRX GRFS CWBR
News Image
5 years ago - By: Halper Sadeh LLP - Mentions: MR CBMG
News Image

About PTI

Company Profile

Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.

Company Info

Proteostasis Ther

80 Guest Street Suite 500

Boston MA 02135

CEO: Meenu Chhabra

Phone: 617-225-0096

Proteostasis Ther / PTI FAQ

What does PTI do?

Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.


What is the current price of PTI stock?

The current stock price of PTI is 1.11 null. The price decreased by -3.48% in the last trading session.


What is the dividend status of Proteostasis Ther?

PTI does not pay a dividend.


How is the ChartMill rating for Proteostasis Ther?

PTI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the market capitalization of PTI stock?

Proteostasis Ther (PTI) has a market capitalization of 57.93M null. This makes PTI a Micro Cap stock.


PTI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to PTI. When comparing the yearly performance of all stocks, PTI is a bad performer in the overall market: 96% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PTI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PTI. PTI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PTI Financial Highlights

Over the last trailing twelve months PTI reported a non-GAAP Earnings per Share(EPS) of -0.75. The EPS increased by 41.41% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -71.38%
ROE N/A
Debt/Equity 0.31
Chartmill High Growth Momentum
EPS Q2Q%36%
Sales Q2Q%N/A
EPS 1Y (TTM)41.41%
Revenue 1Y (TTM)-100%

PTI Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y39.66%
Revenue Next YearN/A

PTI Ownership

Ownership
Inst Owners15.65%
Ins Owners19.48%
Short Float %N/A
Short RatioN/A